FDA places clinical hold on lung cancer trial after patient death
After the death of a study participant, Iovance Biotherapeutics has announced a clinical hold on their trial evaluating LN-145, an experimental non-small cell l
Friedrich Graf Finckenstein Iovance Biotherapeutics Graf Finckenstein Clinical Hold Iovance Biotherapeutics N 145
Source: beckershospitalreview.com